Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Interest Coverage Ratio (2020 - 2025)

Barinthus Biotherapeutics' Interest Coverage Ratio history spans 6 years, with the latest figure at 889.62 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 54.36% year-over-year to 889.62; the TTM value through Dec 2025 reached 1383.43, down 7.87%, while the annual FY2025 figure was 1383.43, 7.87% down from the prior year.
  • Interest Coverage Ratio reached 889.62 in Q4 2025 per BRNS's latest filing, up from 1158.92 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 8.84 in Q1 2022 to a low of 2855.43 in Q4 2023.
  • Average Interest Coverage Ratio over 5 years is 1354.85, with a median of 1466.67 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: tumbled 25191.25% in 2021, then surged 479.46% in 2022.
  • A 5-year view of Interest Coverage Ratio shows it stood at 926.0 in 2021, then soared by 100.95% to 8.84 in 2022, then crashed by 32409.13% to 2855.43 in 2023, then skyrocketed by 31.74% to 1949.17 in 2024, then soared by 54.36% to 889.62 in 2025.
  • Per Business Quant, the three most recent readings for BRNS's Interest Coverage Ratio are 889.62 (Q4 2025), 1158.92 (Q3 2025), and 1943.67 (Q2 2025).